The offi cial sub-categories
were listed as follows:
On Health:
•
•
•
The impact on human health of e-cigarettes
The benefi ts and risks of e-cigarettes as a ‘stop smoking’
tool, any gaps in the knowledge-base on this, and whether
any approaches are needed to tackle e-cigarette
addiction.
The uptake of e-cigarettes among young people and
evidence on whether e-cigarettes play a role in ‘re-
normalising’ smoking.
On regulation:
•
•
•
•
Whether there is any regulatory variation between the EU and UK, and
across UK nations, and the implications of Brexit on regulation in this area.
The effectiveness of regulation on the advertising and marketing of
e-cigarettes.
The impact to date of the Tobacco and Related Products Regulations on
the vaping industry and on the prevalence of e-cigarettes.
The safety of e-cigarette devices, and any safety regulation requirements.
On Finance:
•
•
The economic impact of the UK’s e-cigarette industry.
The public fi nances implications of e-cigarettes, including how
the rise in e-cigarette consumption could affect NHS costs.
Written submissions for the Science and Technology Committee closed
on December 8. The results have yet to be released as of this publication
date, but given how vape companies have proven time and again to have
the experts and data on their side, we are confi dent that the industry
can once again step up to the plate and provide the knowledge so many
smokers so desperately need in their lives.
VM14 | 13